Chemodex

Ropivacaine

CHF 122.00
In stock
CDX-R0124-M05050 mgCHF 122.00
CDX-R0124-M250250 mgCHF 489.00
More Information
Product Details
Synonyms (S)-Ropivacaine; (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide
Product Type Chemical
Properties
Formula C17H26N2O
MW 274.4
CAS 84057-95-4
Source/Host Chemicals Synthetic
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in chloroform or acentonitrile. Slightly soluble in DMSO or methanol.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key ZKMNUMMKYBVTFN-UHFFFAOYSA-N
Smiles CC1=CC=CC(C)=C1NC(C2CCCCN2CCC)=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Ropivacaine is a long-acting amide local anaesthetic agent. Ropivacaine is a potent and reversible blocker of sodium channels in nerve fibers. It is a pure S(-)enantiomer and less lipophilic than racemic sodium channel blockers, such as bupivacaine and is less likely to penetrate large myelinated motor fibres, resulting in a relatively reduced motor blockade. Thus, ropivacaine has a greater degree of motor sensory differentiation, which could be useful when motor blockade is undesirable. The reduced lipophilicity is also associated with decreased potential for central nervous system toxicity and cardiotoxicity.

Product References

(1) R.D. Wang, et al.; Exp. Opin. Pharmacother. 2, 2051 (2001) (Review) | (2) T.G. Hansen; Exp. Rev. Neurother. 4, 781 (2004) (Review) | (3) G. Kuthiala & G. Chaudhary; Indian J. Anaesth. 55, 104 (2011) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.